Macrophage roles following myocardial infarction

Fishbein, 1978, The histopathologic evolution of myocardial infarction, Chest, 73, 843, 10.1378/chest.73.6.843 Lindsey, 2004, MMP induction and inhibition in myocardial infarction, Heart Fail Rev, 9, 7, 10.1023/B:HREV.0000011390.44039.b7 Opie, 2006, Controversies in ventricular remodelling, Lancet, 367, 356, 10.1016/S0140-6736(06)68074-4 Pfeffer, 1990, Ventricular remodeling after myocardial infarction. experimental observations and clinical implications, Circulation, 81, 1161, 10.1161/01.CIR.81.4.1161 Rossen, 1988, Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo, Circ Res, 62, 572, 10.1161/01.RES.62.3.572 Ren, 2003, Inflammatory mechanisms in myocardial infarction, Curr Drug Targets Inflamm Allergy, 2, 242, 10.2174/1568010033484098 Frangogiannis, 2002, The inflammatory response in myocardial infarction, Cardiovasc Res, 53, 31, 10.1016/S0008-6363(01)00434-5 Solomon, 2001, Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study, Ann Intern Med, 134, 451, 10.7326/0003-4819-134-6-200103200-00009 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 Pfeffer, 1995, Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction, Annu Rev Physiol, 57, 805, 10.1146/annurev.ph.57.030195.004105 Solomon, 1997, The decreasing incidence of left ventricular remodeling following myocardial infarction, Basic Res Cardiol, 92, 61, 10.1007/BF00805561 Sutton, 1997, Cardiovascular death and left ventricular remodeling two years after myocardial infarction : baseline predictors and impact of long-term use of captopril: information from the survival and ventricular enlargement (SAVE) Trial, Circulation, 96, 3294, 10.1161/01.CIR.96.10.3294 Solomon, 2002, Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction, Circulation, 106, 1251, 10.1161/01.CIR.0000032313.82552.E3 Lavine, 2003, Prediction of heart failure post myocardial infarction: comparison of ejection fraction, transmitral filling parameters, and the index of myocardial performance, Echocardiography, 20, 691, 10.1111/j.0742-2822.2003.02156.x Hellermann, 2005, Heart failure after myocardial infarction: clinical presentation and survival, Eur J Heart Fail, 7, 119, 10.1016/j.ejheart.2004.04.011 Hellermann, 2003, Incidence of heart failure after myocardial infarction: is it changing over time?, Am J Epidemiol, 157, 1101, 10.1093/aje/kwg078 Lewis, 2003, Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study, J Am Coll Cardiol, 42, 1446, 10.1016/S0735-1097(03)01057-X Anavekar, 2004, Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction, N Engl J Med, 351, 1285, 10.1056/NEJMoa041365 Sanz, 2007, Risk stratification in acute coronary syndromes: an unresolved issue, Rev Esp Cardiol, 60 Suppl 3, 23 Bhatheja, 2007, Acute coronary syndromes: unstable angina/non-ST elevation myocardial infarction, Crit Care Clin, 23, 709, 10.1016/j.ccc.2007.07.003 Sunderkotter, 1994, Macrophages and angiogenesis, J Leukoc Biol, 55, 410, 10.1002/jlb.55.3.410 Lewis, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res, 66, 605, 10.1158/0008-5472.CAN-05-4005 Moldovan, 2000, Contribution of monocytes/macrophages to compensatory neovascularization : the drilling of metalloelastase-positive tunnels in ischemic myocardium, Circ Res, 87, 378, 10.1161/01.RES.87.5.378 Crowther, 2001, Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors, J Leukoc Biol, 70, 478, 10.1189/jlb.70.4.478 Singer, 1999, Cutaneous wound healing, N Engl J Med, 341, 738, 10.1056/NEJM199909023411006 Frangogiannis, 2003, MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype, Am J Physiol Heart Circ Physiol, 285, H483, 10.1152/ajpheart.01016.2002 Mann, 2003, Stress-activated cytokines and the heart: from adaptation to maladaptation, Annu Rev Physiol, 65, 81, 10.1146/annurev.physiol.65.092101.142249 Jaffer, 2006, Molecular imaging of myocardial infarction, J Mol Cell Cardiol, 41, 921, 10.1016/j.yjmcc.2006.09.008 Cathelin, 2006, Identification of proteins cleaved downstream of caspase activation in monocytes undergoing macrophage differentiation, J Biol Chem, 281, 17779, 10.1074/jbc.M600537200 Van Ginderachter, 2006, Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion, Immunobiology, 211, 487, 10.1016/j.imbio.2006.06.002 Porcheray, 2005, Macrophage activation switching: an asset for the resolution of inflammation, Clin Exp Immunol, 142, 481, 10.1111/j.1365-2249.2005.02934.x Stein, 1992, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J Exp Med, 176, 287, 10.1084/jem.176.1.287 Kodelja, 1998, Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern, J Immunol, 160, 1411, 10.4049/jimmunol.160.3.1411 Tormey, 1997, T-cell cytokines may control the balance of functionally distinct macrophage populations, Immunology, 90, 463, 10.1046/j.1365-2567.1997.00207.x Goerdt, 1999, Alternative versus classical activation of macrophages, Pathobiology, 67, 222, 10.1159/000028096 Frangogiannis, 2007, Chemokines in ischemia and reperfusion, Thromb Haemost, 97, 738, 10.1160/TH07-01-0022 Hart, 1989, Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2, Proc Natl Acad Sci U S A, 86, 3803, 10.1073/pnas.86.10.3803 Hart, 1990, Augmentation of glucocorticoid action on human monocytes by interleukin-4, Lymphokine Res, 9, 147 Chizzolini, 2000, Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes, J Immunol, 164, 5952, 10.4049/jimmunol.164.11.5952 Gibbs, 1999, Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Evidence for alveolar macrophage as source of proteinases, Am J Resir Cell Mol Biol, 20, 1145, 10.1165/ajrcmb.20.6.3482 Gibbs, 1999, Characterization of matrix metalloproteinases produced by rat alveolar macrophages, Am J Resir Cell Mol Biol, 20, 1136, 10.1165/ajrcmb.20.6.3483 Song, 2000, Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts, Cell Immunol, 204, 19, 10.1006/cimm.2000.1687 Cao, 2000, The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis, Chin Med J (Eng Ed), 113, 776 Sunderkotter, 1991, Macrophage-derived angiogenesis factors, Pharmacol Ther, 51, 195, 10.1016/0163-7258(91)90077-Y Zhang, 2008, Macrophage activation by endogenous danger signals, J Pathol, 214, 161, 10.1002/path.2284 Goerdt, 1993, Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro, Am J Pathol, 142, 1409 Zwadlo, 1987, A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process, Exp Cell Biol, 55, 295 Mosser, 2003, The many faces of macrophage activation, J Leukoc Biol, 73, 209, 10.1189/jlb.0602325 Erwig, 1998, Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines, J Immunol, 161, 1983, 10.4049/jimmunol.161.4.1983 Weber, 1997, Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation, Circulation, 96, 4065, 10.1161/01.CIR.96.11.4065 Hokimoto, 1995, Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarction, Cardiovasc Res, 29, 664, 10.1016/S0008-6363(96)88638-X Hirsch, 1991, Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure, Circ Res, 69, 475, 10.1161/01.RES.69.2.475 Sun, 1994, Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat, Cardiovasc Res, 28, 1423, 10.1093/cvr/28.9.1423 Ou, 1996, In situ production of angiotensin II by fibrosed rat pericardium, J Mol Cell Cardiol, 28, 1319, 10.1006/jmcc.1996.0122 Napoleone, 2000, Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes, Circ Res, 86, 139, 10.1161/01.RES.86.2.139 Dean, 2005, Connective tissue growth factor and cardiac fibrosis after myocardial infarction, J Histochem Cytochem, 53, 1245, 10.1369/jhc.4A6560.2005 Luikart, 2006, Mactinin treatment promotes wound-healing-associated inflammation in urokinase knockout mice, Wound Repair Regen, 14, 123, 10.1111/j.1743-6109.2006.00101.x Antohe, 2006, vol. 112, 245 Boyle, 2005, Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture, Curr Vasc Pharmacol, 3, 63, 10.2174/1570161052773861 Danenberg, 2002, Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits, Circulation, 106, 599, 10.1161/01.CIR.0000023532.98469.48 Espinosa-Heidmann, 2003, Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization, Investig Ophthalmol Vis Sci, 44, 3586, 10.1167/iovs.03-0038 Sakurai, 2003, Macrophage depletion inhibits experimental choroidal neovascularization, Investig Ophthalmol Vis Sci, 44, 3578, 10.1167/iovs.03-0097 Takayama, 2000, Macrophage depletion prevents accelerated rejection and results in long-term survival in hamster to rat cardiac xenotransplantation, Transplant Proc, 32, 1016, 10.1016/S0041-1345(00)01090-3 Liu, 2000, Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury, Pain, 86, 25, 10.1016/S0304-3959(99)00306-1 Duffield, 2005, Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair, J Clin Invest, 115, 56, 10.1172/JCI200522675 Duffield, 2005, Conditional ablation of macrophages halts progression of crescentic glomerulonephritis, Am J Pathol, 167, 1207, 10.1016/S0002-9440(10)61209-6 Li, 2002, Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury, Cell, 111, 635, 10.1016/S0092-8674(02)01079-6 Suzuki, 2000, Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE, Blood, 96, 2584, 10.1182/blood.V96.7.2584 Aikawa, 2001, An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro, Circulation, 103, 276, 10.1161/01.CIR.103.2.276 Kakio, 2000, Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart, Lab Invest, 80, 1127, 10.1038/labinvest.3780119 Mannisi, 1987, Steroid administration after myocardial infarction promotes early infarct expansion. A study in the rat, J Clin Invest, 79, 1431, 10.1172/JCI112971 Hammerman, 1983, Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation and ventricular function, Circulation, 68, 446, 10.1161/01.CIR.68.2.446 Okazaki, 2007, Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes, Am J Pathol, 171, 1093, 10.2353/ajpath.2007.061191 Yano, 2006, Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair, J Am Coll Cardiol, 47, 626, 10.1016/j.jacc.2005.09.037 van Amerongen, 2007, Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice, Am J Pathol, 170, 818, 10.2353/ajpath.2007.060547 Leor, 2006, Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart, Circulation, 114, I, 10.1161/CIRCULATIONAHA.105.000331 Dobaczewski, 2006, Extracellular matrix remodeling in canine and mouse myocardial infarcts, Cell Tissue Res, 324, 475, 10.1007/s00441-005-0144-6 Jackson, 2001, Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells, J Clin Invest, 107, 1395, 10.1172/JCI12150 Anversa, 1998, Ventricular myocytes are not terminally differentiated in the adult mammalian heart, Circ Res, 83, 1, 10.1161/01.RES.83.1.1 Rossen, 1993, Complement activation in cardiac disease, 75 Horstick, 2002, C1-esterase inhibitor in ischemia and reperfusion, Immunobiology, 205, 552, 10.1078/0171-2985-00154 Deodato, 1999, Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury, Br J Pharmacol, 128, 1683, 10.1038/sj.bjp.0702973 Tsujita, 2007, Targeted deletion of class a macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction, Circulation, 115, 1904, 10.1161/CIRCULATIONAHA.106.671198 Squadrito, 1997, 17beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat, Eur J Pharmacol, 335, 185, 10.1016/S0014-2999(97)01201-6 Frangogiannis, 2006, The mechanistic basis of infarct healing, Antioxid Redox Signal, 8, 1907, 10.1089/ars.2006.8.1907 Moldovan, 2005, Role of monocytes and macrophages in angiogenesis, Exs, 127 Ganz, 1993, Macrophage function, New Horiz, 1, 23 Rappolee, 1988, Secretory products of phagocytes, Curr Opin Immunol, 1, 47, 10.1016/0952-7915(88)90050-7 Nathan, 1987, Secretory products of macrophages, J Clin Invest, 79, 319, 10.1172/JCI112815 Ito, 2003, Inflammatory cytokines and cardiovascular disease, Curr Drug Targets Inflamm Allergy, 2, 257, 10.2174/1568010033484106 Kobusiak-Prokopowicz, 2005, Kinetics of chemokines in acute myocardial infarction, Kardiol Pol, 62, 301 Dewald, 2005, CCL2/monocyte chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts, Circ Res, 96, 881, 10.1161/01.RES.0000163017.13772.3a Dewald, 2005, CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts, Circ Res, 96, 881, 10.1161/01.RES.0000163017.13772.3a Kumar, 1997, Induction of moncyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium, Circulation, 95, 693, 10.1161/01.CIR.95.3.693 Condeelis, 2006, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007 Duffield, 2005, Conditional ablation of macrophages halts progression of crescentic glomerulonephritis, Am J Pathol, 167, 1207, 10.1016/S0002-9440(10)61209-6 Sano, 2003, Critical role of galectin-3 in phagocytosis by macrophages, J Clin Invest, 112, 389, 10.1172/JCI200317592 Maree, 2005, Quantifying macrophage defects in type 1 diabetes, J Theor Biol, 233, 533, 10.1016/j.jtbi.2004.10.030 Camelliti, 2005, Structural and functional characterisation of cardiac fibroblasts, Cardiovasc Res, 65, 40, 10.1016/j.cardiores.2004.08.020 MacKenna, 2000, Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis, Cardiovasc Res, 46, 257, 10.1016/S0008-6363(00)00030-4 Keane, 2006, Inflammation and angiogenesis in fibrotic lung disease, Semin Respir Crit Care Med, 27, 589, 10.1055/s-2006-957331 Willis, 2006, Epithelial origin of myofibroblasts during fibrosis in the lung, Proc Am Thorac Soc, 3, 377, 10.1513/pats.200601-004TK Phillips, 2004, Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis, J Clin Invest, 114, 438, 10.1172/JCI200420997 Chesney, 1998, Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes, J Immunol, 160, 419, 10.4049/jimmunol.160.1.419 Quan, 2004, Circulating fibrocytes: collagen-secreting cells of the peripheral blood, Int J Biochem Cell Biol, 36, 598, 10.1016/j.biocel.2003.10.005 Haudek, 2006, Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice, Proc Natl Acad Sci U S A, 103, 18284, 10.1073/pnas.0608799103 Bouzegrhane, 2002, Is angiotensin II a proliferative factor of cardiac fibroblasts?, Cardiovasc Res, 53, 304, 10.1016/S0008-6363(01)00448-5 Booz, 1995, Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts, Cardiovasc Res, 30, 537, 10.1016/S0008-6363(96)88507-5 Sun, 2000, Infarct scar: a dynamic tissue, Cardiovasc Res, 46, 250, 10.1016/S0008-6363(00)00032-8 Tyagi, 1998, Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells, J Cell Physiol, 176, 374, 10.1002/(SICI)1097-4652(199808)176:2<374::AID-JCP16>3.0.CO;2-3 Siwik, 2001, Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts, Am J Physiol Cell Physiol, 280, C53, 10.1152/ajpcell.2001.280.1.C53 Tummalapalli, 2001, Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts, J Cell Biochem, 80, 512, 10.1002/1097-4644(20010315)80:4<512::AID-JCB1005>3.0.CO;2-N Ahmed, 2004, Connective tissue growth factor—a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats, J Mol Cell Cardiol, 36, 393, 10.1016/j.yjmcc.2003.12.004 Lin, 1998, Molecular cloning of genes differentially regulated by TNF-[alpha] in bovine aortic endothelial cells, fibroblasts and smooth muscle cells, Cardiovasc Res, 38, 802, 10.1016/S0008-6363(98)00055-8 Gurantz, 1999, Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts, Circ Res, 85, 272, 10.1161/01.RES.85.3.272 Desmouliere, 1993, Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts, J Cell Biol, 122, 103, 10.1083/jcb.122.1.103 Sutton, 2000, Left ventricular remodeling after myocardial infarction: pathophysiology and therapy, Circulation, 101, 2981, 10.1161/01.CIR.101.25.2981 Sun, 1997, Fibrous tissue and angiotensin II, J Mol Cell Cardiol, 29, 2001, 10.1006/jmcc.1997.0451 Weber, 1997, Tissue repair and angiotensin II generated at sites of healing, Basic Res Cardiol, 92, 75, 10.1007/BF00805565 Falkenhahn, 1995, Cellular distribution of angiotensin-converting enzyme after myocardial infarction, Hypertension, 25, 219, 10.1161/01.HYP.25.2.219 Guarda, 1993, Effects of endothelins on collagen turnover in cardiac fibroblasts, Cardiovasc Res, 27, 2130, 10.1093/cvr/27.12.2130 Simons, 2005, Angiogenesis: where do we stand now?, Circulation, 111, 1556, 10.1161/01.CIR.0000159345.00591.8F Carmeliet, 2005, Angiogenesis in life, disease and medicine, Nature, 438, 932, 10.1038/nature04478 Murdoch, 2005, Macrophage migration and gene expression in response to tumor hypoxia, Int J Cancer, 117, 701, 10.1002/ijc.21422 Helisch, 2003, Arteriogenesis: the development and growth of collateral arteries, Microcirculation, 10, 83, 10.1080/mic.10.1.83.97 de Muinck, 2004, Re-evaluating therapeutic neovascularization, J Mol Cell Cardiol, 36, 25, 10.1016/j.yjmcc.2003.10.002 Manoonkitiwongsa, 2001, Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis, J Cereb Blood Flow Metab, 21, 1223, 10.1097/00004647-200110000-00011 Ogawa, 1985, Healing of focal injury in the rat liver, Am J Pathol, 119, 158 Kobayashi, 1994, Interferon-gamma-activated macrophages enhance angiogenesis from endothelial cells of rat aorta, Immunopharmacology, 27, 23, 10.1016/0162-3109(94)90004-3 Ono, 1999, Biological implications of macrophage infiltration in human tumor angiogenesis, Cancer Chemother Pharmacol, 43, S69, 10.1007/s002800051101 Nagase, 2006, Structure and function of matrix metalloproteinases and TIMPs, Cardiovasc Res, 69, 562, 10.1016/j.cardiores.2005.12.002 Overall, 2006, Towards third generation matrix metalloproteinase inhibitors for cancer therapy, Br J Cancer, 94, 941, 10.1038/sj.bjc.6603043 Shankavaram, 1998, Lipopolysaccharide induction of monocyte matrix metalloproteinase is regulated by the tyrosine phosphorylation of cytosolic phospholipase A2, J Leukoc Biol, 64, 221, 10.1002/jlb.64.2.221 Ausprunk, 1977, Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis, Microvasc Res, 14, 53, 10.1016/0026-2862(77)90141-8 Ingber, 1989, How does extracellular matrix control capillary morphogenesis?, Cell, 58, 803, 10.1016/0092-8674(89)90928-8 Mignatti, 1989, In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases, J Cell Biol, 108, 671, 10.1083/jcb.108.2.671 Bendeck, 2000, Mining the myocardium with macrophage drills: a novel mechanism for revascularization, Circ Res, 87, 341, 10.1161/01.RES.87.5.341 Falcone, 1998, Macrophage formation of angiostatin during inflammation, J Biol Chem, 273, 31480, 10.1074/jbc.273.47.31480 Patterson, 1997, Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9), J Biol Chem, 272, 28823, 10.1074/jbc.272.46.28823 Davis, 2000, Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules, Am J Pathol, 156, 1489, 10.1016/S0002-9440(10)65020-1 Maquart, 2004, An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity: Implication in tumor invasion, Crit Rev Oncol/Hematol, 49, 199, 10.1016/j.critrevonc.2003.06.007 Schellings, 2004, Matricellular proteins in the heart: possible role during stress and remodeling, Cardiovasc Res, 64, 24, 10.1016/j.cardiores.2004.06.006 Clark, 1988, Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment, J Biol Chem, 263, 12115, 10.1016/S0021-9258(18)37900-6 Xu, 2001, Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo, J Cell Biol, 154, 1069, 10.1083/jcb.200103111 Hangai, 2002, Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis, Am J Pathol, 161, 1429, 10.1016/S0002-9440(10)64418-5 Khan, 2002, Exposure of cryptic domains in the alpha 1-chain of laminin-1 by elastase stimulates macrophages urokinase and MMP-9 expression, J Biol Chem, 277 (16), 13778, 10.1074/jbc.M111290200 Schenk, 2003, Tales from the crypt[ic] sites of the extracellular matrix, Trends Cell Biol, 13, 366, 10.1016/S0962-8924(03)00129-6 Bellon, 2004, Matrix metalloproteinases and matrikines in angiogenesis, Crit Rev Oncol/Hematol, 49, 203, 10.1016/j.critrevonc.2003.10.004 McGavigan, 2006, Serological evidence of altered collagen homeostasis reflects early ventricular remodeling following acute myocardial infarction, Int J Cardiol, 111, 267, 10.1016/j.ijcard.2005.08.045 Visse, 2003, Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry, Circ Res, 92, 827, 10.1161/01.RES.0000070112.80711.3D Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat Rev Cancer, 2, 163, 10.1038/nrc745 Shapiro, 1999, Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth, Thromb Haemost, 82, 846, 10.1055/s-0037-1615921 Sellebjerg, 2003, Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system, Brain Res Bull, 61, 347, 10.1016/S0361-9230(03)00097-2 Lindsey, 2001, Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion, Circulation, 103, 2181, 10.1161/01.CIR.103.17.2181 Ducharme, 2000, Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction, J Clin Invest, 106, 55, 10.1172/JCI8768 Johnson, 2004, Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching, Circ Res, 94, 262, 10.1161/01.RES.0000111527.42357.62 Lindsey, 2006, Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction, Am J Physiol Heart Circ Physiol, 290, H232, 10.1152/ajpheart.00457.2005 Corbitt, 2007, Mechanisms to inhibit matrix metalloproteinase activity: where are we in the development of clinically relevant Inhibitors, Recent Patents Anticancer Drug Discov, 2, 135, 10.2174/157489207780832423 Peterson, 2002, Matrix metalloproteinase inhibitor development for the treatment of heart failure, Drug Dev Res, 55, 29, 10.1002/ddr.10032 Peterson, 2004, Matrix metalloproteinase inhibitor development and the remodeling of drug discovery, Heart Fail Rev, 9, 63, 10.1023/B:HREV.0000011395.11179.af Peterson, 2006, The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors, Cardiovasc Res, 69, 677, 10.1016/j.cardiores.2005.11.032 Cavusoglu, 2006, Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction, Am Heart J, 151, 1101.e1, 10.1016/j.ahj.2006.02.029 Peterson, 2000, Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat, Cardiovasc Res, 46, 307, 10.1016/S0008-6363(00)00029-8 Chirco, 2006, Novel functions of TIMPs in cell signaling, Cancer Metastasis Rev, 25, 99, 10.1007/s10555-006-7893-x Eue, 2001, Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: participation of activated macrophages in the antitumor mechanism, Int J Cancer, 92, 426, 10.1002/ijc.1201 Fujiwara, 2005, Macrophages in inflammation, Curr Drug Targets Inflamm Allergy, 4, 281, 10.2174/1568010054022024 Investigators TAAMI, 2007, Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial, JAMA, 297, 43, 10.1001/jama.297.1.43 Verhoeckx, 2004, A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line, Proteomics, 4, 1014, 10.1002/pmic.200300669 Wagsater, 2008, ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques, Atherosclerosis, 196, 514, 10.1016/j.atherosclerosis.2007.05.018 Droin, 2008, A role for caspases in the differentiation of erythroid cells and macrophages, Biochimie, 90, 416, 10.1016/j.biochi.2007.08.007